SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-20-005508
Filing Date
2020-01-10
Accepted
2020-01-10 17:16:07
Documents
1
Group Members
EDGEPOINT CANADIAN PORTFOLIOEDGEPOINT VARIABLE INCOME PORTFOLIO

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d868215dsc13ga.htm SC 13G/A 65099
  Complete submission text file 0001193125-20-005508.txt   67245
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Subject) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43381 | Film No.: 20521969
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 150 BLOOR STREET W SUITE 500 TORONTO A6 M5S 2X9
Business Address 150 BLOOR STREET W SUITE 500 TORONTO A6 M5S 2X9 416-963-9353
EdgePoint Investment Group Inc. (Filed by) CIK: 0001481669 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0331
Type: SC 13G/A